Long-term Use of Continuous Subcutaneous Hydrocortisone Infusion Therapy in Patients with Congenital Adrenal Hyperplasia

BACKGROUND: In a phase 2 short-term (6 months) study of patients with congenital adrenal hyperplasia (CAH), continuous subcutaneous hydrocortisone infusion (CSHI) was found to be a safe, effective, and well-tolerated method of replacing cortisol with improved disease and patient related outcomes. OB...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Endocrinol (Oxf)
Hlavní autoři: Mallappa, Ashwini, Nella, Aikaterini A., Sinaii, Ninet, Rao, Hamsini, Gounden, Verena, Perritt, Ashley F., Kumar, Parag, Ling, Alexander, Liu, Chia-Ying., Soldin, Steven J., Merke, Deborah P.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2018
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6166869/
https://ncbi.nlm.nih.gov/pubmed/30003563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cen.13813
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky